Shabnam Ghazi‐Noori

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

Emma Hockly, Victoria M. Richon, Benjamin Woodman et al. · Proceedings of the National Academy of Sciences · 2003 · 841 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

Hazel Urwin, Keith A. Josephs, Jonathan D. Rohrer et al. · Acta Neuropathologica · 2010 · 249 citations · Full text

Medicine, Neurology, Pathology +11

Minocycline and doxycycline are not beneficial in a model of Huntington's disease

Donna L. Smith, Benjamin Woodman, Amarbirpal Mahal et al. · Annals of Neurology · 2003 · 172 citations

Life Sciences, Neuroscience, Pharmacology +17

Histological Changes in the Urothelium and Suburothelium of Human Overactive Bladder following Intradetrusor Injections of Botulinum Neurotoxin Type A for the Treatment of Neurogenic or Idiopathic Detrusor Overactivity

Apostolos Apostolidis, Thomas S. Jacques, Alex Freeman et al. · European Urology · 2008 · 158 citations

Medicine, Neuroscience, Urology +17

Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease

Caroline Benn, Christian Landles, Li He et al. · Human Molecular Genetics · 2005 · 127 citations · Full text

Life Sciences, Genetics, Neuroscience +17